Evidence map›Paper›PMID 41012648›Full record

ArticleViruses2025

Generation and Characterization of HDV-Specific Antisera with Respect to Their Application as Specific and Sensitive Research and Diagnostic Tools.

Keerthihan Thiyagarajah, Sascha Hein, Jan Raupach, Nirmal Adeel, Johannes Miller, Maximilian Knapp, Christoph Welsch, Mirco Glitscher, Esra Görgülü, Philipp Stoffers and 5 more

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Keerthihan ThiyagarajahResearch Group, Paul-Ehrlich-Institute, 63225 Langen, Germany.ORCID 0000-0002-1381-8093
Sascha HeinDivision Allergologie-Zentrale Methodenentwicklung, Paul-Ehrlich-Institute, 63225 Langen, Germany.ORCID 0000-0001-7257-4538
Jan RaupachResearch Group, Paul-Ehrlich-Institute, 63225 Langen, Germany.
Nirmal AdeelResearch Group, Paul-Ehrlich-Institute, 63225 Langen, Germany.
Johannes MillerResearch Group, Paul-Ehrlich-Institute, 63225 Langen, Germany.
Maximilian KnappInfectious Diseases Unit, I. Department of Medicine, University Medical Center, Hamburg-Eppendorf, 20038 Hamburg, Germany.
Christoph WelschMedical Clinic 1, University Hospital, Goethe University Frankfurt, 60329 Frankfurt am Main, Germany.ORCID 0000-0002-1823-4863
Mirco GlitscherResearch Group, Paul-Ehrlich-Institute, 63225 Langen, Germany.
Esra GörgülüMedical Clinic 1, University Hospital, Goethe University Frankfurt, 60329 Frankfurt am Main, Germany.ORCID 0000-0002-6324-4470
Philipp StoffersDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Charité-Universitätsmedizin Berlin, 13435 Berlin, Germany.
Pia LembeckDivision Gastroenterology, University Hospital Münster, 48147 Münster, Germany.
Jonel TrebickaDivision Gastroenterology, University Hospital Münster, 48147 Münster, Germany.
Sandra CiesekInstitute of Medical Virology, University Hospital Frankfurt, 60329 Frankfurt am Main, Germany.
Kai-Henrik PeifferDivision Gastroenterology, University Hospital Münster, 48147 Münster, Germany.
Eberhard HildtResearch Group, Paul-Ehrlich-Institute, 63225 Langen, Germany.

Funding

This research was funded by Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz (LOEWE) of the State of Hessen, Research Initiative ACLF-I TP7
6 · The paper itself

Abstract

The hepatitis D virus (HDV) is a small, defective RNA virus that induces the most severe form of viral hepatitis. Despite its severity, HDV infections are under-diagnosed due to non-standardized and costly diagnostic screening methods. However, limited research has been conducted on characterizing HDV-specific antibodies as alternative tools for diagnosis. Thus, we generated HDV-specific, polyclonal antibodies by immunizing rabbits with the HDV protein, small hepatitis delta antigen (SHDAg), in its oligomeric or denatured form. We identified SHDAg-specific linear epitopes by peptide array analysis and compared them to epitopes identified in HDV-infected patients. Using in silico structural analysis, we show that certain highly immunogenic domains in SHDAg, such as the coiled-coil domain, are masked in the oligomeric conformation of the protein; others, such as the second arginine-rich motif, are exposed. The nuclear localization signal is presumably exposed only by specific interaction of oligomeric HDAg with the HDV-RNA genome. Through surface plasmon resonance analysis, we identified two polyclonal antibodies derived from rabbit antisera with affinities in the lower nanomolar range. These antibodies were used to establish an ELISA that can quantitatively detect HDV virions in vitro and upon further optimization could be used as a promising alternative diagnostic screening method.

Indexed as

Antibodies, ViralHepatitis AntibodiesHepatitis DHepatitis Delta VirusImmune SeraAnimalsEnzyme-Linked Immunosorbent AssayEpitopesHepatitis delta AntigensHumansRabbitsAntibodies, ViralEpitopesHepatitis AntibodiesHepatitis delta AntigensImmune SeraB-cell epitopehepatitis D viruspolyclonal antibodiesquantitative ELISA

Identifiers

PMID41012648
PMCPMC12474247

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.